Hannah M. Gunter

University Of Cape Town And Groote Schuur Hospital
Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pharmacogenomics of current antiretroviral drugs.

Pharmacogenomics of current antiretroviral drugs.

Journal: Pharmacogenomics

Published: May 12, 2026

Genetic polymorphisms and adverse reactions to antituberculosis therapy.

Genetic polymorphisms and adverse reactions to antituberculosis therapy.

Journal: Pharmacogenomics

Published: June 20, 2025

Signal Monitoring for Adverse Events Following Immunisation with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System.

Signal Monitoring for Adverse Events Following Immunisation with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System.

Journal: Drug safety

Published: March 17, 2025

Cefepime-induced neurotoxicity.

Cefepime-induced neurotoxicity.

Journal: Southern African journal of infectious diseases

Published: November 09, 2024

Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.

Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.

Journal: Drug safety

Published: October 28, 2024

Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening.

Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening.

Journal: Vaccine

Published: July 26, 2024

Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update.

Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update.

Journal: Southern African journal of HIV medicine

Published: December 08, 2023

Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy-Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method.

Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy-Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method.

Journal: Pharmacoepidemiology and drug safety

Published: November 17, 2023

Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury.

Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury.

Journal: British journal of clinical pharmacology

Published: October 24, 2022

Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort.

Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort.

Journal: Southern African journal of HIV medicine

Published: February 01, 2022

Adult medical emergency unit presentations due to adverse drug reactions in a setting of high HIV prevalence.

Adult medical emergency unit presentations due to adverse drug reactions in a setting of high HIV prevalence.

Journal: African journal of emergency medicine : Revue africaine de la medecine d'urgence

Published: July 14, 2020

A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.

A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 07, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026